OpportunityAnalyzer: NASH – Opportunity Analysis and Forecasts to 2026

2017-05-08
Price :
Published : May-2017
No. of Pages : 171

OpportunityAnalyzer: NASH – Opportunity Analysis and Forecasts to 2026

Summary

Nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and it is therefore a potentially fatal condition.

It is estimated that the 2016 sales for the nonalcoholic steatohepatitis (NASH) market at approximately $618m across the 7MM, encompassing the US, the five major European Union countries (5EU: France, Germany, Italy, Spain, and UK), and Japan. Over the course of the 10-year forecast period, the NASH market will grow at a Compound Annual Growth Rate (CAGR) of 45.0% across the 7MM.

The US and Japanese markets are both anticipated to grow significantly, recording CAGRs of 48.1% and 50.7%, respectively, while the 5EU will record a CAGR of 30.6%. At the end of 2026, the US will contribute around 88% of global sales, while the 5EU and Japan will account for around 10% and 2% of sales, respectively. The higher sales numbers for the US can be attributed to the higher prices of pharmaceuticals and the greater diagnosed prevalence of NASH in the region, as well as the launch of more pipeline agents in this region.

Major drivers of growth in the NASH market include –
– The growing rate of obesity and diabetes globally, leading to an increase in the number of NASH cases.
– The launches of multiple late-stage pipeline products, which will transform the market from one dominated by the use of off-label generics to a burgeoning, competitive space.

The report “OpportunityAnalyzer: NASH – Opportunity Analysis and Forecasts to 2026” analyzes the nuances of the NASH treatment landscape and provides detailed insights into the market dynamics of this highly competitive space. The analysis also includes the evaluation of the commercial and clinical profiles of the late-stage pipeline candidates, and their sales forecasts for the NASH indication over the 2016-2026 time periods.

In particular, this report provides the following –
– Overview of NASH, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies.
– Topline NASH market revenue from 2016-2026. Annual cost of therapy (ACOT) and major pipeline product sales in this forecast period are included.
– Key topics covered include current treatment options, unmet needs and opportunities, and the drivers and barriers affecting NASH therapeutics sales in the 7MM.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.
– Analysis of the current and future market competition in the global NASH therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Companies mentioned in this report: Gilead Sciences, Intercept Pharmaceuticals, Genfit SA, Allergan Plc, Galectin Therapeutics, Galmed Pharmaceuticals, Inventiva Pharma, Novo Nordisk, Conatus Pharmaceuticals, Novartis, Immuron Limited, Cirius Therapeutics.

Scope

– Overview of NASH, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies.
– Topline NASH market revenue from 2016-2026. Annual cost of therapy (ACOT) and major pipeline product sales in this forecast period are included.
– Key topics covered include current treatment options, unmet needs and opportunities, and the drivers and barriers affecting NASH therapeutics sales in the 7MM.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.
– Analysis of the current and future market competition in the global NASH therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global NASH therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the NASH therapeutics market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

BRIC Hydrocephalus Shunting Procedures Outlook to 2025

BRIC Hydrocephalus Shunting Procedures Outlook to 2025 Summary GlobalData's new report, BRIC Hydrocephalus Shunting Procedures Outlook to 2025, provides key procedures data on the BRIC Hydrocephalus Shunting Procedures. The report provides procedure volumes within market segments - New Hydrocephalus Shunts Procedures and Revision Hydrocephalus Shunts Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the......
$3995

United Kingdom Patient Monitoring Accessories Market Outlook to 2025

United Kingdom Patient Monitoring Accessories Market Outlook to 2025 Summary GlobalData's new report, United Kingdom Patient Monitoring Accessories Market Outlook to 2025, provides key market data on the United Kingdom Patient Monitoring Accessories market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Patient Monitoring Leads and Electrodes, Patient Monitoring Temperature Probes and Non-Invasive Blood Pressure Cuffs. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and dea......
$4995

China Fetal Monitors Market Outlook to 2025

China Fetal Monitors Market Outlook to 2025 Summary GlobalData's new report, China Fetal Monitors Market Outlook to 2025, provides key market data on the China Fetal Monitors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Antepartum Monitors and Intrapartum Monitors. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the......
$4995

Canada Neonatal Monitors Market Outlook to 2025

Canada Neonatal Monitors Market Outlook to 2025 Summary GlobalData's new report, Canada Neonatal Monitors Market Outlook to 2025, provides key market data on the Canada Neonatal Monitors market. The report provides value in millions of US dollars, volume (in units), average prices (USD) and company share within market segment. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company ......
$4995

North America ICP Procedures Outlook to 2025

North America ICP Procedures Outlook to 2025 Summary GlobalData's new report, North America ICP Procedures Outlook to 2025, provides key procedures data on the North America ICP Procedures. The report provides procedure volumes within market segment - ICP Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Usi......
$3995

France Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

France Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData's new report, France Neurology Procedures Outlook to 2025, provides key procedures data on the France Neurology Procedures. The report provides procedure volumes within market categories - Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the pro......
$3995

Germany Remote Patient Monitoring Market Outlook to 2025

Germany Remote Patient Monitoring Market Outlook to 2025 Summary GlobalData's new report, Germany Remote Patient Monitoring Market Outlook to 2025, provides key market data on the Germany Remote Patient Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - External Remote Patient Monitoring Devices and Implantable Remote Patient Monitoring Devices. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are con......
$4995

Japan Micro-Electromechanical Sensors Market Outlook to 2025

Japan Micro-Electromechanical Sensors Market Outlook to 2025 Summary GlobalData's new report, Japan Micro-Electromechanical Sensors Market Outlook to 2025, provides key market data on the Japan Micro-Electromechanical Sensors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segment. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate ......
$4995

EU5 Neuromodulation Procedures Outlook to 2025

EU5 Neuromodulation Procedures Outlook to 2025 Summary GlobalData's new report, EU5 Neuromodulation Procedures Outlook to 2025, provides key procedures data on the EU5 Neuromodulation Procedures. The report provides procedure volumes within market segments - Deep Brain Stimulators Procedures, Gastric Electric Stimulators Procedures, Peripheral Nerve Stimulators Procedures, Sacral Nerve Stimulators Procedures, Spinal Cord Stimulators Procedures and Vagus Nerve Stimulators Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model......
$3995

Brazil Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

Brazil Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData's new report, Brazil Neurology Procedures Outlook to 2025, provides key procedures data on the Brazil Neurology Procedures. The report provides procedure volumes within market categories - Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the pro......
$3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy